Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mindbio Therapeutics Corp. ( (TSE:MBIO) ) has provided an announcement.
MindBio Therapeutics has engaged Venture Liquidity Providers to act as a market maker for its common shares on the Canadian Securities Exchange, with services executed through registered broker W.D. Latimer Co. Ltd. Under the 12‑month agreement, MindBio will pay VLP a monthly fee, while VLP and the company remain at arm’s length and W.D. Latimer supplies the capital and stock needed to support orderly trading.
The move is aimed at improving liquidity and maintaining a more stable trading environment for MindBio’s securities as it advances its AI voice‑based intoxication detection platform. Enhanced market making could support investor confidence and access to capital, reinforcing the company’s positioning in the emerging niche of AI-enabled safety and compliance technologies.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a biotechnology company focused on commercializing AI-driven voice analytics to detect drug and alcohol intoxication. Its prediction model leverages more than 50 million data points to assess alcohol impairment with high accuracy using the human voice, and it is building an enterprise platform with Edge-AI kiosks for safety-critical sectors such as mining, aviation, construction and law enforcement.
Average Trading Volume: 12,836
Technical Sentiment Signal: Sell
Current Market Cap: C$5.27M
For a thorough assessment of MBIO stock, go to TipRanks’ Stock Analysis page.